Is there a need to teach pharmacogenetics?

Clinical Pharmacology and Therapeutics

Volumn 95, Issue 3, 2014, Pages 245-247

  Daly, A K ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENTS; CURRICULUM; EDUCATION, MEDICAL; EDUCATION, PHARMACY; NEOPLASMS; PHARMACOGENETICS; SCHOOLS, MEDICAL;

EID: 84894443111     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.184     Document Type: Review

References (5)

1. Passamani, E. Educational challenges in implementing genomic medicine. Clin. Pharmacol. Ther. 94, 192-195 (2013).
2. Gurwitz, D. et al. Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J. 5, 221-225 (2005).
3. Nikola, T.J., Green, J.S., Harralson, A.F. & O'Brien, T.J. The current and future state of pharmacogenomics medical education in the USA. Pharmacogenomics 13, 1419-1425 (2012).
4. Stanek, E.J. et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin. Pharmacol. Ther. 91, 450-458 (2012).
5. Murphy, J.E. et al. Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am. J. Pharm. Educ. 74, 7 (2010).